Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
104.8 USD | -1.26% | -1.56% | -4.94% |
29/04 | Abbott's Dissolving Stent Gets FDA Approval For Arteries Below the Knee | MT |
26/04 | Dexcom's profit beats estimates on strong glucose monitor demand | RE |
- Stock Market
- Equities
- ABT Stock
- News Abbott Laboratories
- Trading Ideas